These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 8458362)

  • 1. A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.
    Northridge DB; Rose E; Raftery ED; Lahiri A; Elder AT; Shaw TR; Henderson E; Dargie HJ
    Eur Heart J; 1993 Mar; 14(3):403-9. PubMed ID: 8458362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical consequences of angiotensin-converting enzyme inhibitor withdrawal in chronic heart failure: a double-blind, placebo-controlled study of quinapril. The Quinapril Heart Failure Trial Investigators.
    Pflugfelder PW; Baird MG; Tonkon MJ; DiBianco R; Pitt B
    J Am Coll Cardiol; 1993 Nov; 22(6):1557-63. PubMed ID: 8227822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of ACE inhibitors on exercise capacity in the treatment of congestive heart failure.
    Riegger GA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S41-6. PubMed ID: 1691406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of angiotensin converting enzyme inhibition on myocardial function and blood pressure after coronary artery bypass surgery--a randomised study.
    Webb CM; Underwood R; Anagnostopoulos C; Bennett JG; Pepper J; Lincoln C; Collins P
    Eur J Cardiothorac Surg; 1998 Jan; 13(1):42-8. PubMed ID: 9504729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE inhibition in patients with mild to moderate congestive heart failure.
    Pelliccia F; Borghi A; Ruggeri A; Cianfrocca C; Morgagni GL; Bugiardini R
    Clin Cardiol; 1993 Aug; 16(8):607-12. PubMed ID: 8370193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of quinapril on exercise tolerance in patients with mild to moderate heart failure.
    Riegger GA
    Eur Heart J; 1991 Jun; 12(6):705-11. PubMed ID: 1830551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview of quinapril, a new ACE inhibitor.
    Frank GJ; Knapp LE; Olson SC; Phelps MC; Quade MM; Rieger MM; Sedman AJ
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S14-23. PubMed ID: 1691402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
    Plosker GL; Sorkin EM
    Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-related effects of ACE inhibition in man: quinapril in patients with moderate congestive heart failure. The Study Group on Neurohormonal Regulation in Congestive Heart Failure: Lausanne, Switzerland; Berlin, Düsseldorf, Munich, Germany.
    Nussberger J; Fleck E; Bahrmann H; Delius W; Schultheiss HP; Brunner HR
    Eur Heart J; 1994 Dec; 15 Suppl D():113-22. PubMed ID: 7713100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of quinapril in healthy volunteers and in patients with hypertension and congestive heart failure.
    Sedman AJ; Posvar E
    Angiology; 1989 Apr; 40(4 Pt 2):360-9. PubMed ID: 2539762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.
    Culy CR; Jarvis B
    Drugs; 2002; 62(2):339-85. PubMed ID: 11817979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic response and pharmacokinetics after the first dose of quinapril in patients with congestive heart failure.
    Squire IB; Macfadyen RJ; Lees KR; Hillis WS; Reid JL
    Br J Clin Pharmacol; 1994 Aug; 38(2):117-23. PubMed ID: 7981011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quinapril in patients with congestive heart failure: controlled trial versus captopril.
    Acanfora D; Furgi G; Trojano L; Picone C; Iannuzzi GL; Rossi M; Papa A; Rengo C; Rengo F
    Am J Ther; 1997; 4(5-6):181-8. PubMed ID: 10423609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinapril in chronic heart failure.
    Northridge DB; Dargie HJ
    Am J Hypertens; 1990 Nov; 3(11):283S-287S. PubMed ID: 2261147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and tolerability of quinapril.
    Knapp LE; Frank GJ; McLain R; Rieger MM; Posvar E; Singer R
    J Cardiovasc Pharmacol; 1990; 15 Suppl 2():S47-55. PubMed ID: 1691407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety profile of quinapril: is there a difference among ACE inhibitors?
    Canter D; Frank GJ; Knapp LE; McLain RW
    Clin Cardiol; 1990 Jun; 13(6 Suppl 7):VII39-42. PubMed ID: 2189620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digoxin, converting-enzyme inhibition (quinapril), and the combination in patients with congestive heart failure functional class II and sinus rhythm.
    Kromer EP; Elsner D; Riegger GA
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):9-14. PubMed ID: 1696671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin-converting enzyme inhibitor dosing interval on functional parameters in patients with chronic heart failure.
    Krum H; Karrasch J; Hamer A; Hare D; Howes LG; Jackson B; Leslie P
    Am Heart J; 1998 Feb; 135(2 Pt 1):237-41. PubMed ID: 9489970
    [No Abstract]   [Full Text] [Related]  

  • 19. Beneficial effects of a single dose of quinapril on left ventricular performance in chronic mitral regurgitation.
    Schön HR; Schröter G; Blömer H; Schömig A
    Am J Cardiol; 1994 Apr; 73(11):785-91. PubMed ID: 8160617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of quinapril and quinaprilat in patients with congestive heart failure.
    Begg EJ; Robson RA; Ikram H; Richards AM; Bammert-Adams JA; Olson SC; Posvar EL; Reece PA; Sedman AJ
    Br J Clin Pharmacol; 1994 Mar; 37(3):302-4. PubMed ID: 8198942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.